Duration of Clopidogrel-Based Dual Antiplatelet Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention ― A Real-World Observation in Taiwan From 2012 to 2015 ―

Author:

Li Yi-Heng1,Chiu Yu-Wei2,Cheng Jun-Jack3,Hsieh I-Chang4,Lo Ping-Han5,Lei Meng-Huan6,Ueng Kwo-Chang7,Chiang Fu-Tien8,Sung Shih-Hsien9,Kuo Jen-Yuan10,Chen Ching-Pei11,Lai Wen-Ter12,Lee Wen-Lieng13,Chen Jyh-Hong14,

Affiliation:

1. National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University

2. Department of Computer Science and Engineering, Yuan Ze University, Far Eastern Memorial Hospital

3. Shin Kong Wu Ho-Su Memorial Hospital

4. Chang Gung Memorial Hospital, Chang Gung University College of Medicine

5. China Medical University Hospital and College of Medicine

6. Lotung Poh-Ai Hospital

7. Chung Shan Medical University Hospital

8. National Taiwan University Hospital and Fu-Jen Catholic University Hospital

9. Taipei Veterans General Hospital and National Yang Ming University

10. Mackay Memorial Hospital

11. Changhua Christian Hospital

12. Kaohsiung Medical University Hospital

13. Taichung Veterans General Hospital

14. College of Medicine, China Medical University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference23 articles.

1. 1. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016; 68: 1082–1115.

2. 2. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213–260.

3. 3. Ozaki Y, Katagiri Y, Onuma Y, Amano T, Muramatsu T, Kozuma K, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018. Cardiovasc Interv Ther 2018; 33: 178–203.

4. 4. Li YH, Wang YC, Wang YC, Liu JC, Lee CH, Chen CC, et al. 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome. J Formos Med Assoc 2018; 117: 766–790.

5. 5. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494–502.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3